Skip to content

Drug interactions

Haemophilus influenzae type b vaccine + Secukinumab

Severity: Minor

Haemophilus influenzae type b vaccine and Secukinumab: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Secukinumab is an IL-17A inhibitor with modest immunomodulatory effects, and the antibody response to non-live vaccines appears largely preserved. Inactivated vaccines such as Hib conjugate can be given, though response may theoretically be somewhat reduced.

What this interaction means in plain words

Haemophilus influenzae type b vaccine and Secukinumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

IL-17A inhibition may slightly blunt immune response; effect on inactivated vaccine response is minimal.

What to do

Where possible, complete recommended vaccinations before starting secukinumab. Non-live vaccines may be given during therapy without interruption.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Haemophilus influenzae type b vaccine and Secukinumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Haemophilus influenzae type b vaccine with Secukinumab?

MediHelp rates the interaction as minor. Haemophilus influenzae type b vaccine and Secukinumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Secukinumab is an IL-17A inhibitor with modest immunomodulatory effects, and the antibody response to non-live vaccines appears largely preserved. Inactivated vaccines such as Hib conjugate can be given, though response may theoretically be somewhat reduced.

How serious is the interaction between Haemophilus influenzae type b vaccine and Secukinumab?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible, complete recommended vaccinations before starting secukinumab. Non-live vaccines may be given during therapy without interruption.

What other medicines interact with Secukinumab?

MediHelp also lists interactions of Secukinumab with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Secukinumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in